Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Machine Learning (1)
- (-) Materials Science (1)
- (-) Nanotechnology (3)
- (-) Neutron Science (1)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (1)
- Biology (1)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (3)
- Coronavirus (4)
- Energy Storage (1)
- Environment (1)
- High-Performance Computing (1)
- Isotopes (1)
- Materials (2)
- Molten Salt (1)
- Physics (1)
- Summit (2)
- Sustainable Energy (1)
Media Contacts
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![Paul Kent, shown above posing with Summit in April 2018, received the 2020 ORNL Director’s Award for Outstanding Individual Accomplishment in Science and Technology. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/DA_Kent.jpg?h=48cf6540&itok=Ocw9WcgV)
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
![ORNL Sign](/sites/default/files/styles/list_page_thumbnail/public/2020-11/ORNLsign.jpg?h=22d0129c&itok=YoZbTjCS)
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
![An organic solvent and water separate and form nanoclusters on the hydrophobic and hydrophilic sections of plant material, driving the efficient deconstruction of biomass. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/dark_image_small.png?h=2e111cc1&itok=drKqW05b)
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.